Salesforce stock rises as Bank of America double upgrades the software stock with AI disruption unlikely to occur.

Bristol Myers Squibb is making a $4.1 billion bet on radiopharmaceutical cancer drugs ahead of a major patent cliff in 2028.

After the stock nearly tripled over the past year, stronger execution and growing CPU demand could fuel further upside.

Fundamentals were recently strong: Applied Optoelectronics posted record second-quarter 2026 revenue of $191.9 million and ...

Valion Bio Inc. shares have been trading down by -15.86 percent after reports of disappointing clinical trial results ...

Juuuust in time to impress your in-laws who are visiting for the holidays.

Zscaler is rated hold after a recent price surge erased its prior risk/reward asymmetry, despite strong business momentum.

Bank of America just flipped its Salesforce call from Underperform to Buy in a single move, arguing the AI threat that spooked investors was overblown. Whether the upgrade holds up depends on one ...

Netcapital Inc. stocks have been trading down by -11.07 percent amid bearish sentiment over its deteriorating financial ...

The Audi TT is frequently remembered as the ultimate small coupe style leader, especially from Europe. It even looked good ...

MARA Holdings Inc. stocks have been trading down by -7.19 percent following sharply negative sentiment from its latest ...

Many investors forget that the Novelis aluminum supplier factory fire hindered Ford's most profitable product. Now, finally, ...